Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study

Lancet

Volumn 354, Issue 9186, 1999, Pages 1234-1241

  Napoli, Claudio ^a,b   Glass, Christopher K ^a   Witztum, Joseph L ^a   Deutsch, Reena ^a   D'Armiento, Francesco P ^b   Palinski, Wulf ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ABDOMINAL AORTA; ADOLESCENT; AORTA ARCH; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAUSE OF DEATH; CHILD; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; IMAGING; INJURY; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033539313     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)02131-5     Document Type: Article

References (47)

1. Lowering blood cholesterol to prevent coronary heart disease. JAMA. 153:1985;2080-2086.
2. Hebert P.R., Gaziano J.M., Chan K.S., Hennekens C.H. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA. 278:1997;313-321.
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389.
4. Shepherd J., Cobbe S.M., Ford I.et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med. 333:1995;1301-1307.
5. Byington R.P., Jukema J.W., Salonen J.T.et al. Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation. 92:1995;2419-2425.
6. Sacks F.M., Pfeffer M.A., Moye L.A.et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 335:1996;1001-1009.
7. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
8. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
9. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
10. Berliner J.A., Navab M., Fogelman A.M.et al. Atherosclerosis: basic mechanisms: oxidation inflammation, and genetics. Circulation. 91:1995;2488-2496.
11. Steinberg D., Witztum J.L. Lipoproteins, lipoprotein oxidation, and atherogenesis. Chien K.R. Molecular basis of cardiovascular disease. 1999;458-475 WB Saunders, Philadelphia.
12. Grundy S.M., Bilheimer D., Chait A.et al. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult-Treatment-Panel-II). JAMA. 269:1993;3015-3023.
13. Natural history of aortic and coronary atherosclerotic lesions in youth: findings from the PDAY study. Arterioscler Thromb. 13:1993;1291-1298.
14. Berenson G.S., Srinivasan S.R., Bao W., Newman W.P. 3rd, Tracy R.E., Wattigney W.A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 338:1998;1606-1650.
15. Napoli C., D'Armiento F.P., Mancini F.P., Witztum J.L., Palumbo G., Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 100:1997;2680-2690.
16. Napoli C., Witztum J.L., de Nigris F., Palumbo G., D'Armiento F.P., Palinski W. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation. 99:1999;2003-2010.
17. Palinski W., Witztum J.L. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 2000. 1999;. (in press).
18. Pyörälä K., De Backer G., Graham I., Poole-Wilson P., Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis. 110:1994;121-161.
19. LaRosa J.C., Hunninghake D., Bush D.et al. The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease - joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation. 81:1990;1721-1733.
20. Napoli C., Leccese M., Palumbo G.et al. Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia. Coronary Artery Dis. 9:1998;257-264.
21. Montes A., Walden C.E., Knopp R.H., Cheung M., Chapman M.B., Albers J.J. Physiologic and supraphysiologic increases in lipoprotein lipids and apoproteins in late pregnancy and postpartum: possible markers for the diagnosis of "prelipemia" Arteriosclerosis. 4:1984;407-417.
22. Berge L.N., Arnesen E., Forsdahl A. Pregnancy related changes in some cardiovascular risk factors. Acta Obstet Gynecol Scand. 75:1996;439-442.
23. Kilby M.D., Neary R.H., Mackness M.I., Durrington P.N. Fetal and maternal lipoprotein metabolism in human pregnancy complicated by type I diabetes mellitus. J Clin Endocrinol Metab. 83:1998;1736-1741.
24. Palinski W., Ylä-Herttuala S., Rosenfeld M.E.et al. Antisera and monoclonal antibodies specific for epitopes generated during the oxidative modification of low density lipoprotein. Arteriosclerosis. 10:1990;325-335.
25. Gown A.M., Tsukada T., Ross R. Human atherosclerosis: immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 125:1986;191-207.
26. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 89:1992;525-570. (suppl 3).
27. Barker D.J., Winter P.D., Osmond C., Margetts B., Simmonds S.J. Weight in infancy and death from ischaemic heart disease. Lancet. 2:1989;577-580. (8663).
28. Kramer M.S., Joseph K.S. Enigma of fetal/infant-origins hypothesis. Lancet. 348:1996;1254-1255.
29. Martyn C.N., Gale C.R., Jespersen S., Sherriff S.B. Impaired fetal growth and atherosclerosis of carotid and peripheral arteries. Lancet. 352:1998;173-178.
30. McMurry M.P., Connor W.E., Goperud C.P. The effects of dietary cholesterol upon the hypercholesterolemia of pregnancy. Metabolism. 30:1982;869-879.
31. Brunner E., White I., Thorogood M., Bristow A., Curle D., Marmot M. Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials. Am J Public Health. 87:1997;1415-1422.
32. Stary H.C., Chandler A.B., Glagov S.et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 89:1994;2462-2478.
33. Blankenhorn D.H., Hodis H.N. George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal. Arterioscler Thromb. 14:1994;177-192.
34. Paigen B., Mitchell D., Reue K., Morrow A., Lusis A.J., LeBoef R.C. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci USA. 84:1987;3763-3767.
35. Paigen B., Nesbitt M.N., Mitchell D., Albee D., LeBoeuf R.C. Ath-2, a second gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Genetics. 122:1989;163-168.
36. Cullen P., Cignarella A., Brennhausen B., Mohr S., Assmann G., von Eckardstein A. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J Clin Invest. 101:1998;1670-1677.
37. Boren J., Olin K., Lee I., Chait A., Wight T.N., Innerarity T.L. Identification of the principal proteoglycan-binding site in LDL: a single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest. 101:1998;2658-2664.
38. Palinski W., Rosenfeld M.E., Ylä-Herttuala S.et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 86:1989;1372-1376.
39. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 10:1998;248-253.
40. Ricote M., Huang J., Fajas L.et al. Expression of the peroxisome proliferator-activated receptor γ in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA. 95:1998;7614-7619.
41. Aaronson S.A. Growth factors and cancer. Science. 254:1991;1146-1153.
42. Belknap W.M., Dietschy J.M. Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta and fetus: sources for tissue cholesterol during fetal development. J Clin Invest. 82:1988;2077-2085.
43. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
44. Napoli C., Ambrosio G., Scarpato N.et al. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia. Am Heart J. 133:1997;585-595.
45. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
46. Reaven P.D., Napoli C., Merat S., Witztum J.L. Lipoproteinmodification and atherosclerosis in aging. Exp Gerontol. 34:1999;527-537.
47. Bosmam H., Marmot M.G., Hemingway H., Nicholson A.C., Brunner E., Stansfeld S.A. Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study. BMJ. 314:1997;558-565.